Sentence examples for baseline were treated with from inspiring English sources

High caries risk adults (1 8 frank cavities at baseline) were treated with Chlorhexidine rinse and fluoride rinse (0.05% NaF) over a three-year period.

RA patients with HDA at baseline were treated with the TNF inhibitor adalimumab (n = 120) and the IL-6R inhibitor tocilizumab (n = 97).

57 In this study, 140 subjects with moderate to severe glabellar lines at baseline were treated with either 10 U (n = 45) onabotulinumtoxinA, 20 U (n = 46) onabotulinumtoxinA, or placebo (n = 49).

34– 38 A dose-range study in drug naïve type 2 diabetic patients with an HbA1c of 6.8%9.7%% (mean 7.9%) at baseline were treated with saxagliptin in a dose range from 2.5 mg to 40 mg once daily.

Only patients with CXH scores <9 or FIGO scores <7 at baseline are treated with single-agent methotrexate (18) and were therefore included in this study; high-risk patients were excluded.

At 4 months, patients who did not achieve American College of Rheumatology (ACR) Pediatric 70 (Pedi 70) improvement from baseline were treated (or retreated) with open-label MTX, etanercept, and prednisolone.

At 4 months, those patients not achieving an ACR pediatric 70 improvement from baseline were treated (or retreated) with open label MEP.

The P-value of the Hosmer and Lemeshow goodness-of-fit test was 0.47.> Patients diagnosed with COPD or both COPD and asthma by theirs GPs at baseline, were treated more often with antibiotics and systemic corticosteroids during exacerbations than the patients only diagnosed with asthma.

In addition, individuals who were using oral antidiabetic therapy (a biguanide, sulfonylurea, thiazolidinedione, or acarbose) at baseline were treated as a separate cohort, with progression to use of insulin as the study outcome.

Following recording of a baseline, cells were treated with a mix of forskolin (25 µM) and the phosphodiesterase inhibitor IBMX (100 µM) to saturate cAMP binding to EPAC [1] (Figure 4).

At baseline, 36% were treated with an antidepressant, this proportion remains high throughout the follow-up period, with a significantly higher rate for MS vs. PM at 24 months (55% vs. 27%, p < 0.001).